BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
AstraZeneca India gets CDSCO Marketing Approval for Palivizumab, a Preventive Therapy for RSV October 4, 2023 AstraZeneca Pharma India, a leading biopharmaceutical company has received marketing approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute €˜Palivizumab injection 100 mg/ml (r-DNA origin) in India.
AstraZeneca's Rare Disease Unit Buys Pfizer Portfolio September 20, 2023 The global pharma giant AstraZeneca's rare disease unit Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.
British-Swedish Pharma Giant AstraZeneca's Alexion Partners with USA's Verge Genomics in a $840 Mn+ Deal September 13, 2023 British-Swedish pharmaceutical major, AstraZeneca, has formed a partnership between its rare disease unit, Alexion, with American biotechnology firm Verge Genomics. The partnership deal is reported to be valued at over $840 million
